Oncology & Cancer
Pox vaccines extend survival for patients with melanoma, ovarian cancer
An immunotherapy regimen incorporating poxviruses and targeting a particular tumor antigen, NY-ESO-1, has shown promise in treating two types of cancers. Kunle Odunsi, MD, PhD, Chair of the Department of Gynecologic Oncology ...
Mar 26, 2012
0
1